: COVID-19: infection-associated enhanced disease

diagnosis > symptomatology > second phase of the disease > lung disease > infection-associated enhanced disease

infection-associated enhanced disease

Antibody-dependent enhancement (ADE), sometimes less precisely called immune enhancement or disease enhancement, is a phenomenon in which binding of a virus to suboptimal antibodies enhances its entry into host cells, followed by its replication. Antiviral antibodies promote viral infection of target immune cells by exploiting the phagocytic FcγR or complement pathway. After interaction with the virus the antibody binds Fc receptors (FcR) expressed on certain immune cells or some of the complement proteins. (Wikipédia)

http://data.loterre.fr/ark:/67375/C0X-GGJVKFJT-9

RDF/XML TURTLE JSON-LD Dernière modification le 05/01/2021

Loterre